The Assessment That Ended the Respirator Program

There are at least five defects, and they compound rather than cancel.

1. Invalid sample volume. Pump flow fell from 200 to 118 mL/min, a 41% drop. Good practice accepts drift of about 5% for a valid sample. A pump that loses that much flow has an unknown flow history, so the volume - and therefore the concentration - cannot be reconstructed from either the pre- or post-shift calibration. Using the post-shift number does not fix it. The sample is void, and with it the only quantitative exposure number in the report.
2. Single sample, single operator, four-person group. One sample cannot describe four people doing different tasks in different positions. It is a data point, not an exposure profile, and it says nothing about the high-exposure task.
3. Method selectivity. Sampling and analysis targeted toluene only. Roughly half of the solvent is d-limonene and up to a fifth is isopropanol, and neither was measured. The report's 'all exposures' is a conclusion about one component of a mixture.
4. Misuse of the PID. A photoionization detector reading on an isobutylene calibration is a screening number, not an exposure measurement. The response varies by compound and by lamp energy; isopropanol, with an ionization potential just under the lamp's, responds weakly, and a mixture produces a composite response that cannot be attributed to any one component. The correct use is to apply the instrument's published correction factor for a known single compound, or to treat output as a relative indicator of where to sample. A 210 ppm peak is not 210 ppm of anything in particular, but it is a large signal and it flatly contradicts 'well below limits.'
5. Ventilation assertion without measurement. There is no capture velocity, airflow, or hood-face data. General dilution ventilation does not control a solvent source - it dilutes what has already escaped.

Net effect: the conclusion rests on one invalid sample and one uninterpretable one. It is not supported.

On the respirator program: no. The decision to cancel cannot rest on data that cannot be defended. The practical sequence is:

• Determine what the respirators are currently doing. If they are required by the employer, the full written program - medical evaluation, fit testing, training, cartridge change schedules - has to stay in place until repeat sampling shows exposures below the levels that require protection.
• If they are used voluntarily, the applicable requirements are narrower, but cancelling is still a decision made on evidence, and there isn't any yet.
• Keep the program in place until the resampling is complete and the ventilation is fixed. Tell management the cost of a program you might not need is far below the cost of a decision you cannot defend.

On the dermatitis: this is the most specific signal in the file and the report ignores it. Contact dermatitis on the forearms is a dermal exposure finding, and respirators do nothing about it. D-limonene is a recognized skin sensitizer and is a plausible cause; toluene and isopropanol defat the skin and make it more permeable. The correct response is glove selection based on manufacturer permeation data for the actual solvent blend - nitrile is often a poor choice for limonene and laminated film or PVA may be better - plus aprons, a review of how the wipe-down is performed (wringing rags by hand, solvent on forearms), and referral for skin assessment. Headaches in three of four operators are nonspecific on their own, but combined with a 210 ppm PID peak and an open degreaser lid they are consistent with a real exposure, and they need to be taken seriously rather than explained away.

The assessment has to answer three questions: what is the mixture exposure, what is driving it, and what is the skin exposure.

Structuring the sampling

• Define similar exposure groups by task, not by job title: degreaser operation, manual wipe-down, cleanup, and any maintenance that involves opening the machine.
• Sample across shifts and across the people most likely to be highest exposed. As a working target, aim for enough full-shift personal samples per group to see the distribution and the high end - on the order of six to ten per group, not one - and be explicit that the number is chosen to characterize the high-exposure group rather than to produce a single number.
• Include short-term samples for the tasks that produce peaks: lid-open periods, rag changes, spraying. Full-shift averages can hide a ceiling problem.

Analytical

• Use methods that cover all three components in the same sample set rather than toluene alone; verify the current method numbers and desorption behavior against the current NIOSH manual before the samples are shipped.
• Recheck pump calibration before and after every sample and record it; a repeat of the 41% drift means the sampling plan, not just the sample, failed.
• Use the PID as a screening tool to find the sources and the peak tasks, with the correction factor applied for a known compound where one exists, and with the results reported as relative, not as exposure.

Engineering and dermal

• Measure the degreaser's exhaust airflow and capture velocity and compare to design; check whether the lid interlocks or alarms, because leaving it open defeats whatever ventilation exists.
• Add surface wipe sampling and glove permeation review to address the dermal route directly.
• Feed all of it back into a written exposure assessment that states its own confidence limits, so the next person can see what the data do and do not support.